A combination of genetically engineered oncolytic virus and melittin-CpG for cancer viro-chemo-immunotherapyAmirhossein Bahreyni, Honglin Luo|BMC Medicine|2023Cited by 20
Engineering a facile and versatile nanoplatform to facilitate the delivery of multiple agents for targeted breast cancer chemo-immunotherapyAmirhossein Bahreyni, Honglin Luo|Research Square|2023Cited by 0